AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Orum Therapeutics, Inc.

₩49950 -$63850.00 (-56.11%)
KOE · 14 Sep 2026 06:30 UTC
Previous Close
₩51000
Day Range
₩48250₩50700
Year Range
₩31250₩146600
Market Cap
1.06T
AVG Volume
181.44K
Trailing/Forward PE
57.9/-
PEG ratio
-0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
KOSDAQKR
Revenue (KRW)
010B20B30B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Revenue (KRW) by quarter
PeriodRevenue (KRW)
26 Q224.11M
26 Q10
25 Q4558.17K
25 Q315.89M
25 Q24.16M
25 Q12.95M
24 Q42.46M
24 Q320.87B
24 Q216.19M
24 Q115.36M
Net Income (KRW)
-20B020B40B60B80B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Net Income (KRW) by quarter
PeriodNet Income (KRW)
26 Q263.38B
26 Q1-15.28B
25 Q4-15.97B
25 Q3-13.62B
25 Q2-3.77B
25 Q1-8.6B
24 Q4-10.82B
24 Q314.43B
24 Q2-1.69B
24 Q1-7.55B
Operating Income (KRW)
-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Operating Income (KRW) by quarter
PeriodOperating Income (KRW)
26 Q2-15.35B
26 Q1-18.08B
25 Q4-18.25B
25 Q3-13.94B
25 Q2-10B
25 Q1-9.57B
24 Q4-6.84B
24 Q313.44B
24 Q2-5.86B
24 Q1-5.96B
EBITDA (KRW)
-25B025B50B75B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ EBITDA (KRW) by quarter
PeriodEBITDA (KRW)
26 Q264.7B
26 Q1-13.98B
25 Q4-16.71B
25 Q3-12.51B
25 Q2-2.4B
25 Q1-7.35B
24 Q4-7.12B
24 Q313.51B
24 Q2-5.72B
24 Q1-6.06B
Cash Flows (KRW)
-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Cash Flows (KRW) by quarter
PeriodCash Flows (KRW)
26 Q2-19.07B
26 Q1-15.39B
25 Q4-11.87B
25 Q3-6.42B
25 Q2-11.01B
25 Q1-7.39B
24 Q4-10.42B
24 Q312B
24 Q2-7.84B
24 Q1-6.19B
EPS (KRW)
-200002000400024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ EPS (KRW) by quarter
PeriodEPS (KRW)
26 Q22937.73
26 Q1-677
25 Q4-752.38
25 Q3-646
25 Q2-179
25 Q1-433
24 Q4-587.85
24 Q3773
24 Q2-132.92
24 Q1-1651.09
Expenses (KRW)
05B10B15B20BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Expenses (KRW) by quarter
PeriodExpenses (KRW)
26 Q212.88B
26 Q115.29B
25 Q415.75B
25 Q311.44B
25 Q27.82B
25 Q17.2B
24 Q45.64B
24 Q35.44B
24 Q23.67B
24 Q13.51B
Cash & Debt (KRW)
0100B200B300BCashShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Cash & Debt (KRW) by quarter
PeriodCash & Debt (KRW)
26 Q2251.9B
26 Q1274.23B
25 Q491.5M
25 Q3143.66B
25 Q2148.77B
25 Q1158.45B
24 Q4118.07B
24 Q3124.18B
24 Q2112.77B
24 Q10
Debt ratios
-200204024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Debt ratios by quarter
PeriodDebt ratios
26 Q2-7.24
26 Q15.43
25 Q40
25 Q34.89
25 Q236.92
25 Q119.73
24 Q416.69
24 Q3-0.81
24 Q2-0.85
24 Q10
Margins
0%25%50%75%100%23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q2
475830.KQ Margins by quarter
PeriodMargins
26 Q2100%
25 Q4100%
25 Q3100%
25 Q2100%
25 Q1100%
24 Q4100%
24 Q3100%
24 Q291.67%
24 Q196.95%
23 Q4100%
Return on Capital
-20000%-15000%-10000%-5000%0%5000%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Return on Capital by quarter
PeriodReturn on Capital
26 Q234.08%
26 Q1-12.78%
25 Q4-17688.4%
25 Q3-13233.39%
25 Q2-2.4%
25 Q1-5.32%
24 Q4-8.94%
24 Q311.03%
24 Q2-1.45%
24 Q1-5.87%
Shares Outstanding
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Shares Outstanding by quarter
PeriodShares Outstanding
26 Q221.57M
26 Q122.58M
25 Q421.23M
25 Q321.08M
25 Q221.07M
25 Q119.87M
24 Q418.41M
24 Q318.67M
24 Q212.75M
24 Q14.61M
Book Value Per Share (KRW)
010000200003000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Book Value Per Share (KRW) by quarter
PeriodBook Value Per Share (KRW)
26 Q28621.68
26 Q15295.9
25 Q44.25
25 Q34.88
25 Q27458.83
25 Q18140.58
24 Q46574.46
24 Q37008.05
24 Q29146.96
24 Q127886.42
Total Assets (KRW)
0100B200B300B400B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Total Assets (KRW) by quarter
PeriodTotal Assets (KRW)
26 Q2291.99B
26 Q1312.82B
25 Q4116.83M
25 Q3129.26M
25 Q2185.73B
25 Q1191.52B
24 Q4152.89B
24 Q3159.94B
24 Q2147.87B
24 Q10
PE Ratio
4567med 5.16Feb 25Feb 25Feb 25Mar 25Mar 25Mar 25Mar 25
475830.KQ PE Ratio by quarter
PeriodPE Ratio
Mar 255.08
Mar 254.49
Mar 255.68
Mar 255.16
Feb 256.35
Feb 256.37
Feb 254.12
Free Cash Flow Yield
-10%0%10%20%30%med -2.35%Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
475830.KQ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-3.88%
Sep 26-3.54%
Aug 26-3%
Aug 26-3.19%
Aug 26-2.91%
Aug 26-3.2%
Jul 26-4.44%
Jul 26-4.35%
Jul 26-4.36%
Jul 26-4.06%
Jul 26-3.79%
Jun 26-3.5%
Jun 26-2.79%
Jun 26-2.54%
Jun 26-2.74%
May 26-2.55%
May 26-2.4%
May 26-2.27%
May 26-2.09%
Apr 26-1.96%
Apr 26-2.05%
Apr 26-2.01%
Apr 26-2%
Apr 26-2.17%
Mar 26-1.49%
Mar 26-1.32%
Mar 26-1.2%
Mar 26-1.43%
Feb 26-1.28%
Feb 26-1.52%
Feb 26-1.45%
Feb 26-1.53%
Jan 26-1.48%
Jan 26-1.42%
Jan 26-1.37%
Jan 26-1.16%
Jan 26-1.47%
Dec 25-0.77%
Dec 25-0.76%
Dec 25-0.87%
Dec 25-0.97%
Nov 25-1.4%
Nov 25-1.44%
Nov 25-1.53%
Nov 25-1.57%
Oct 25-1.74%
Oct 25-2.35%
Oct 25-2.48%
Oct 25-2.28%
Oct 25-2.36%
Sep 25-2.16%
Sep 25-1.91%
Sep 25-2.13%
Sep 25-2.24%
Aug 25-2.67%
Aug 25-2.74%
Aug 25-2.71%
Aug 25-2.97%
Aug 25-3.31%
Jul 25-2.92%
Jul 25-2.99%
Jul 25-3.29%
Jul 25-3.75%
Jun 25-3.58%
Jun 25-3.75%
Jun 25-3.79%
Jun 25-3.97%
May 25-3.5%
May 25-3.7%
May 25-3.2%
May 25-3.97%
May 25-3.71%
Apr 25-2.65%
Apr 25-2.45%
Apr 25-2.42%
Apr 25-2.41%
Mar 2522.92%
Mar 2525.9%
Mar 2520.48%
Mar 2522.58%
Feb 2518.35%
Feb 2518.26%
Feb 2528.28%
Price to Sales
050000100000150000med 57.53Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
475830.KQ Price to Sales by quarter
PeriodPrice to Sales
Sep 2655868.71
Sep 2661236.49
Aug 2672300.69
Aug 2667918.83
Aug 2674601.16
Aug 2667809.28
Jul 2648857.74
Jul 2649843.66
Jul 2649734.11
Jul 2653349.14
Jul 2657183.27
Jun 2644421.4
Jun 2655864.65
Jun 2661180.8
Jun 2656855.79
May 2661090.69
May 2664784.97
May 2668479.24
May 2674336.02
Apr 2679471.96
Apr 2675957.9
Apr 2677399.57
Apr 2677759.98
Apr 2671903.21
Mar 2693023.57
Mar 26104527.38
Mar 26115451.85
Mar 2697078.87
Feb 26107837.82
Feb 2690789.02
Feb 2695589.17
Feb 2690209.69
Jan 2693520.14
Jan 2697244.39
Jan 26100803.12
Jan 26118927.82
Jan 2694182.23
Dec 25105.27
Dec 25105.97
Dec 2592.25
Dec 2582.96
Nov 2557.53
Nov 2556.01
Nov 2552.58
Nov 2551.27
Oct 2546.43
Oct 2534.31
Oct 2532.45
Oct 2535.37
Oct 2534.16
Sep 2530.25
Sep 2534.24
Sep 2530.63
Sep 2529.2
Aug 2524.45
Aug 2523.88
Aug 2524.11
Aug 2521.97
Aug 2519.74
Jul 2522.35
Jul 2521.88
Jul 2519.83
Jul 2517.43
Jun 2516.62
Jun 2515.89
Jun 2515.69
Jun 2514.99
May 2517
May 2516.1
May 2518.62
May 2515
May 2516.02
Apr 2522.45
Apr 2524.26
Apr 2524.57
Apr 2524.74
Mar 253.23
Mar 252.86
Mar 253.61
Mar 253.28
Feb 254.03
Feb 254.05
Feb 252.62
EV/EBITDA
2.533.544.5med 3.4Feb 25Feb 25Feb 25Mar 25Mar 25Mar 25Mar 25
475830.KQ EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 253.34
Mar 252.86
Mar 253.83
Mar 253.4
Feb 254.38
Feb 254.4
Feb 252.55
Price/Operating Cashflow
3.544.555.56med 4.5Feb 25Feb 25Feb 25Mar 25Mar 25Mar 25Mar 25
475830.KQ Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 254.44
Mar 253.92
Mar 254.96
Mar 254.5
Feb 255.54
Feb 255.57
Feb 253.59
Price to Book
0100002000030000med 7.64Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
475830.KQ Price to Book by quarter
PeriodPrice to Book
Sep 269.63
Sep 2610.56
Aug 2612.46
Aug 2611.71
Aug 2612.86
Aug 2611.69
Jul 268.42
Jul 268.59
Jul 268.57
Jul 269.2
Jul 269.86
Jun 2611590.34
Jun 2614576.09
Jun 2615963.17
Jun 2614834.7
May 2615939.66
May 2616903.56
May 2617867.46
May 2619395.6
Apr 2620735.66
Apr 2619818.78
Apr 2620194.94
Apr 2620288.98
Apr 2618760.84
Mar 2623016.68
Mar 2625863.05
Mar 2628566.08
Mar 2624020.08
Feb 2626682.15
Feb 2622463.79
Feb 2623651.48
Feb 2622320.45
Jan 2623139.55
Jan 2624061.03
Jan 2624941.56
Jan 2629426.13
Jan 2623303.37
Dec 2513.98
Dec 2514.08
Dec 2512.25
Dec 2511.02
Nov 257.64
Nov 257.44
Nov 256.99
Nov 256.81
Oct 256.17
Oct 254.56
Oct 254.31
Oct 254.7
Oct 254.54
Sep 253.91
Sep 254.42
Sep 253.96
Sep 253.77
Aug 253.16
Aug 253.08
Aug 253.11
Aug 252.84
Aug 252.55
Jul 252.89
Jul 252.83
Jul 252.56
Jul 252.25
Jun 252.87
Jun 252.75
Jun 252.71
Jun 252.59
May 252.94
May 252.78
May 253.22
May 252.59
May 252.77
Apr 253.88
Apr 254.19
Apr 254.24
Apr 254.27
Mar 253.84
Mar 253.4
Mar 254.3
Mar 253.9
Feb 254.79
Feb 254.82
Feb 253.11
Orum Therapeutics, Inc.
475830.KQ
Stockpicker

Video analysis: 475830.KQ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.